AI filing briefs

Bakkt, Inc. (BKKT)

BKKT 8-K filings, explained

Every material Form 8-K Bakkt, Inc. has filed with the SEC since June 04, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs on record4since Jun 04, 2026
Latest filingNov 09, 2026earnings
High impact (4-5)3of 4 briefs
ToneMixed2Neutral2
earnings 2leadership 1m&a 1

2026

Nov 9, 4:34 PM ET

Bakkt Q3 revenue down 62.9% to $149.2 million; sets $6 billion 1H27 volume target

Mixed earnings 2.02

Bakkt reported third-quarter 2026 revenue of $149.2 million, down 62.9% from $402.2 million a year earlier, mainly due to lower crypto trading volume and the loss of clients. The company posted net income of $14.3 million, or $0.31 per diluted share, versus a net loss of $14.9 million in Q3 2025, and the filing notes the result includes a $26.8 million non-cash gain on the Transchem warrants. It reiterated a full-year 2026 Total Transacting Volume target of approximately $3 billion and set a first-half 2027 target of approximately $6 billion.

  • Q3 2026 total revenue was $149.2 million versus $402.2 million in Q3 2025; net income attributable to Bakkt was $14.3 million, or $0.31 per diluted share
  • Adjusted EBITDA loss narrowed to $11.8 million from $14.8 million in Q3 2025 on a consistent basis
  • TTV was $147.9 million for Q3 2026; the company reiterated its approximately $3 billion full-year 2026 target and set an approximately $6 billion first-half 2027 target
  • Cash, cash equivalents and restricted cash were $37.3 million as of September 30, 2026, versus $50.7 million as of June 30, 2026
Read the filing on SEC.gov ↗
Aug 17, 8:00 AM ET

Bakkt names Matt White chief financial officer, replacing Karen Alexander

Neutral leadership Written later 5.027.01

Bakkt said CFO Karen Alexander left the role effective August 14, 2026, and that the separation was not the result of any disagreement with management or the external auditor. Matt White, a former CFO of CoreCard Corporation, became Bakkt's CFO effective August 17, 2026, with a $300,000 base salary and equity awards priced at $10.00 per share.

  • Karen Alexander's CFO role and employment ended effective August 14, 2026; she will serve as an advisor until December 31, 2026.
  • Matt White, age 44, was appointed CFO effective August 17, 2026, after serving as CFO and Corporate Secretary of CoreCard Corporation (NYSE: CCRD).
  • White's package includes a $300,000 base salary, 90,000 RSUs and 60,000 options with a $10.00 exercise price, granted as inducement awards without shareholder approval.
  • Alexander will receive $400,000 annualized consulting fees, a $200,000 cash payment for forfeited equity awards, and up to $160,000 tied to the Specified Arbitration recovery.
Read the filing on SEC.gov ↗
Aug 10, 4:31 PM ET

Bakkt Q2 net income $80.8 million on $98.5 million warrant gain; revenue down 70%

Mixed earnings Written later 2.02

Bakkt reported second-quarter 2026 results with revenue of $170.1 million, down 70.0% from $568.1 million a year earlier, which the company attributed to previously disclosed client transitions and industry-wide softness in digital asset trading volumes. GAAP net income of $80.8 million, or $1.94 per diluted share, was driven by a $98.5 million non-cash gain on the Transchem warrants, while the adjusted EBITDA loss widened to $11.8 million. Shareholders face a sharp revenue decline, and the company reaffirmed its full-year 2026 TTV expectation of approximately $2.5 billion, which depends on client launches ramping in the second half.

  • Total revenue was $170.1 million in Q2 2026 versus $568.1 million in Q2 2025, a 70.0% decline.
  • Net income attributable to Bakkt was $80.8 million ($1.94 per diluted share), compared with a net loss of $14.7 million in Q2 2025; the result includes a $98.5 million non-cash gain on Transchem warrants.
  • Adjusted EBITDA loss was $11.8 million, compared with $9.8 million in Q2 2025.
  • Cash, cash equivalents and restricted cash were $50.7 million as of June 30, 2026, with no long-term debt; the company continues to expect approximately $2.5 billion of full-year 2026 TTV.
Read the filing on SEC.gov ↗
Jun 4, 8:34 AM ET

Bakkt pays $9.4 million for Transchem warrants after Indian committee approves allotment

Neutral m&a Written later 8.01

Bakkt said Transchem's Preferential Issue Committee approved the allotment of 47,500,000 warrants to Bakkt Opco Holdings, LLC on June 3, 2026. Bakkt paid $9,409,784 for the warrants, which equals 25% of the total subscription amount and entitle the holder to acquire Transchem ordinary shares. The filing is a routine update on a previously reported investment and does not report operating results.

  • Allotment of 47,500,000 warrants approved by Transchem's Preferential Issue Committee on June 3, 2026
  • Bakkt paid $9,409,784, equal to 25% of the total subscription amount
  • Original subscription election was reported on November 21, 2025
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Bakkt, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →